| Product Code: ETC11227837 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The Argentina tyrosine kinase inhibitors market experienced a negative CAGR of -6.11% from 2020 to 2024. However, in 2023-2024, there was a year-on-year growth rate of 10.40%. This increase in imports during 2023-2024 can be attributed to this positive growth rate, despite the overall declining trend during the period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Tyrosine Kinase Inhibitors Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, 2022 & 2032F |
3.3 Argentina Tyrosine Kinase Inhibitors Market - Industry Life Cycle |
3.4 Argentina Tyrosine Kinase Inhibitors Market - Porter's Five Forces |
3.5 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
3.8 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume Share, By Mode of Action, 2022 & 2032F |
4 Argentina Tyrosine Kinase Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Argentina, driving the demand for tyrosine kinase inhibitors. |
4.2.2 Growing investments in healthcare infrastructure and research development in Argentina. |
4.2.3 Rising awareness about targeted cancer therapies among healthcare providers and patients. |
4.3 Market Restraints |
4.3.1 High cost associated with tyrosine kinase inhibitors limiting affordability for a significant portion of the population. |
4.3.2 Stringent regulatory requirements for approval and commercialization of tyrosine kinase inhibitors in Argentina. |
5 Argentina Tyrosine Kinase Inhibitors Market Trends |
6 Argentina Tyrosine Kinase Inhibitors Market, By Types |
6.1 Argentina Tyrosine Kinase Inhibitors Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Small Molecule TKIs, 2022 - 2032F |
6.1.4 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Large Molecule TKIs, 2022 - 2032F |
6.1.5 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Multi-Targeted TKIs, 2022 - 2032F |
6.1.6 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Specific TKIs, 2022 - 2032F |
6.2 Argentina Tyrosine Kinase Inhibitors Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Oncology, 2022 - 2032F |
6.2.3 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Inflammatory Diseases, 2022 - 2032F |
6.2.4 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Cardiovascular, 2022 - 2032F |
6.2.5 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Neurology, 2022 - 2032F |
6.3 Argentina Tyrosine Kinase Inhibitors Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
6.3.3 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Retail Pharmacies, 2022 - 2032F |
6.3.4 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Direct Sales, 2022 - 2032F |
6.4 Argentina Tyrosine Kinase Inhibitors Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.4 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.5 Argentina Tyrosine Kinase Inhibitors Market, By Mode of Action |
6.5.1 Overview and Analysis |
6.5.2 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Reversible, 2022 - 2032F |
6.5.3 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Irreversible, 2022 - 2032F |
6.5.4 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Others, 2022 - 2032F |
6.5.5 Argentina Tyrosine Kinase Inhibitors Market Revenues & Volume, By Others, 2022 - 2032F |
7 Argentina Tyrosine Kinase Inhibitors Market Import-Export Trade Statistics |
7.1 Argentina Tyrosine Kinase Inhibitors Market Export to Major Countries |
7.2 Argentina Tyrosine Kinase Inhibitors Market Imports from Major Countries |
8 Argentina Tyrosine Kinase Inhibitors Market Key Performance Indicators |
8.1 Patient survival rates post-treatment with tyrosine kinase inhibitors. |
8.2 Number of clinical trials and research studies conducted on tyrosine kinase inhibitors in Argentina. |
8.3 Adoption rate of tyrosine kinase inhibitors in different types of cancer treatments in Argentina. |
9 Argentina Tyrosine Kinase Inhibitors Market - Opportunity Assessment |
9.1 Argentina Tyrosine Kinase Inhibitors Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Argentina Tyrosine Kinase Inhibitors Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Argentina Tyrosine Kinase Inhibitors Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
9.4 Argentina Tyrosine Kinase Inhibitors Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Argentina Tyrosine Kinase Inhibitors Market Opportunity Assessment, By Mode of Action, 2022 & 2032F |
10 Argentina Tyrosine Kinase Inhibitors Market - Competitive Landscape |
10.1 Argentina Tyrosine Kinase Inhibitors Market Revenue Share, By Companies, 2025 |
10.2 Argentina Tyrosine Kinase Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here